Logo image of EMBK

Embark Technology Inc (EMBK) Stock Fundamental Analysis

NASDAQ:EMBK - Nasdaq - US29079J2024 - Common Stock - Currency: USD

2.88  +0.01 (+0.35%)

After market: 2.87 -0.01 (-0.35%)

Fundamental Rating

1

EMBK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. While EMBK seems to be doing ok healthwise, there are quite some concerns on its profitability. EMBK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year EMBK has reported negative net income.
In the past year EMBK has reported a negative cash flow from operations.
EMBK Yearly Net Income VS EBIT VS OCF VS FCFEMBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

The profitability ratios for EMBK are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMBK Yearly ROA, ROE, ROICEMBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -10 -20 -30 -40 -50

1.3 Margins

EMBK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMBK Yearly Profit, Operating, Gross MarginsEMBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

4

2. Health

2.1 Basic Checks

EMBK has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, EMBK has a worse debt to assets ratio.
EMBK Yearly Shares OutstandingEMBK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
EMBK Yearly Total Debt VS Total AssetsEMBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.84, we must say that EMBK is in the distress zone and has some risk of bankruptcy.
EMBK's Altman-Z score of -3.84 is on the low side compared to the rest of the industry. EMBK is outperformed by 85.71% of its industry peers.
EMBK has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
EMBK has a Debt to Equity ratio (0.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.84
ROIC/WACCN/A
WACCN/A
EMBK Yearly LT Debt VS Equity VS FCFEMBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

EMBK has a Current Ratio of 11.38. This indicates that EMBK is financially healthy and has no problem in meeting its short term obligations.
EMBK has a Current ratio of 11.38. This is amongst the best in the industry. EMBK outperforms 96.43% of its industry peers.
A Quick Ratio of 11.38 indicates that EMBK has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 11.38, EMBK belongs to the best of the industry, outperforming 96.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.38
Quick Ratio 11.38
EMBK Yearly Current Assets VS Current LiabilitesEMBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M 250M

More info and screens

0

3. Growth

3.1 Past

EMBK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.60%, which is quite good.
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, EMBK will show a very negative growth in Earnings Per Share. The EPS will decrease by -27.35% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMBK Yearly Revenue VS EstimatesEMBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
EMBK Yearly EPS VS EstimatesEMBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMBK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMBK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMBK Price Earnings VS Forward Price EarningsEMBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMBK Per share dataEMBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 -6

4.3 Compensation for Growth

A cheap valuation may be justified as EMBK's earnings are expected to decrease with -27.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.35%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMBK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Embark Technology Inc

NASDAQ:EMBK (8/1/2023, 8:00:02 PM)

After market: 2.87 -0.01 (-0.35%)

2.88

+0.01 (+0.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-10 2023-08-10
Earnings (Next)11-06 2023-11-06
Inst Owners1.62%
Inst Owner Change0%
Ins Owners2.19%
Ins Owner Change0%
Market Cap70.20M
Analysts43.33
Price Target3.06 (6.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.37%
Min EPS beat(2)18.37%
Max EPS beat(2)18.37%
EPS beat(4)3
Avg EPS beat(4)30.66%
Min EPS beat(4)5.24%
Max EPS beat(4)68.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)-4.44
EYN/A
EPS(NY)-7.2
Fwd EYN/A
FCF(TTM)-4.9
FCFYN/A
OCF(TTM)-4.49
OCFYN/A
SpS0
BVpS5.16
TBVpS5.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 368%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.38
Quick Ratio 11.38
Altman-Z -3.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)349.02%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.4%
EPS Next Y-69.54%
EPS Next 2Y-27.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.75%
EBIT Next 3Y-10.05%
EBIT Next 5Y-11.83%
FCF growth 1Y-57.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.07%
OCF growth 3YN/A
OCF growth 5YN/A